Search

Your search keyword '"Puertas, Maria C."' showing total 270 results

Search Constraints

Start Over You searched for: Author "Puertas, Maria C." Remove constraint Author: "Puertas, Maria C."
270 results on '"Puertas, Maria C."'

Search Results

2. Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome

4. Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

6. Sustained aviraemia despite anti-retroviral therapy non-adherence in male children following in utero hiv transmission

8. Gut microbiome signatures linked to HIV-1 reservoir size and viremia control

9. Targeting Viral Transcription for HIV Cure Strategies.

10. HIGH-FREQUENCY failure of combination antiretroviral therapy in paediatric HIV infection is associated with unmet maternal needs causing maternal NON-ADHERENCE

11. Exploring the HIV-1 Rev Recognition Element (RRE)–Rev Inhibitory Capacity and Antiretroviral Action of Benfluron Analogs

13. Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)

14. Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals

15. Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy

18. Definition of the viral targets of protective HIV-1-specific T cell responses

21. Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission

22. Author Correction: Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection

23. Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection

28. Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects

35. IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation

38. Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome

40. Additional file 2 of Gut microbiome signatures linked to HIV-1 reservoir size and viremia control

50. Supplementary material from Romero-Puertas et al., 2021

Catalog

Books, media, physical & digital resources